tiprankstipranks
Consun Pharmaceutical Group Ltd. (DE:C1P)
FRANKFURT:C1P
Germany Market
C1P
Consun Pharmaceutical Group Ltd.
RESEARCH TOOLSreports

Consun Pharmaceutical Group Ltd. (C1P) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

C1P Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Consun
Pharmaceutical Group Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

C1P Stock 12 Month Forecast

Average Price Target

€2.18
▲(28.31% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Consun Pharmaceutical Group Ltd. in the last 3 months. The average price target is €2.18 with a high forecast of €2.39 and a low forecast of €1.98. The average price target represents a 28.31% change from the last price of €1.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","3":"€3","0.75":"€0.75","1.5":"€1.5","2.25":"€2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.3858432,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.1812627200000003,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€2.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.9766822400000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,1.4296802461538463,1.5093604923076924,1.5890407384615386,1.6687209846153848,1.748401230769231,1.828081476923077,1.907761723076923,1.9874419692307694,2.0671222153846154,2.1468024615384618,2.2264827076923077,2.3061629538461537,{"y":2.3858432,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,1.4139432861538463,1.4778865723076924,1.5418298584615386,1.6057731446153847,1.669716430769231,1.7336597169230772,1.7976030030769232,1.8615462892307695,1.9254895753846157,1.9894328615384618,2.0533761476923083,2.1173194338461543,{"y":2.1812627200000003,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,1.3982063261538462,1.4464126523076923,1.4946189784615385,1.5428253046153848,1.591031630769231,1.639237956923077,1.6874442830769232,1.7356506092307693,1.7838569353846156,1.8320632615384618,1.880269587692308,1.928475913846154,{"y":1.9766822400000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.022,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.268,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.363,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.582,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.738,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.582,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.592,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.874,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.757,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.777,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.476,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€2.39Average Price Target€2.18Lowest Price Target€1.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
China Everbright Analyst forecast on DE:C1P
Unknown Analyst
China Everbright
Not Ranked
China Everbright
€1.98
Buy
16.28%
Upside
Reiterated
07/02/26
China Everbright Sticks to Its Buy Rating for Consun Pharmaceutical Group Ltd. (C1P)
Guoyuan Securities (HK) Analyst forecast on DE:C1P
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€2.39
Buy
40.34%
Upside
Reiterated
04/22/26
Consun Pharmaceutical Group Ltd. (C1P) Gets a Buy from Guoyuan Securities (HK)
First Shanghai Securities Analyst forecast on DE:C1P
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
€2.82
Buy
65.92%
Upside
Reiterated
04/15/26
First Shanghai Securities Remains a Buy on Consun Pharmaceutical Group Ltd. (C1P)
DBS Analyst forecast on DE:C1P
Mark Kong CFA
DBS
DBS
€2.9
Buy
70.51%
Upside
Reiterated
03/27/26
Consun Pharmaceutical Group Ltd. (C1P) Receives a Buy from DBS
China Merchants Securities Analyst forecast on DE:C1P
Unknown Analyst
China Merchants Securities
Not Ranked
China Merchants Securities
€1.77
Buy
4.27%
Upside
Reiterated
08/28/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
China Everbright Analyst forecast on DE:C1P
Unknown Analyst
China Everbright
Not Ranked
China Everbright
€1.98
Buy
16.28%
Upside
Reiterated
07/02/26
China Everbright Sticks to Its Buy Rating for Consun Pharmaceutical Group Ltd. (C1P)
Guoyuan Securities (HK) Analyst forecast on DE:C1P
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€2.39
Buy
40.34%
Upside
Reiterated
04/22/26
Consun Pharmaceutical Group Ltd. (C1P) Gets a Buy from Guoyuan Securities (HK)
First Shanghai Securities Analyst forecast on DE:C1P
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
€2.82
Buy
65.92%
Upside
Reiterated
04/15/26
First Shanghai Securities Remains a Buy on Consun Pharmaceutical Group Ltd. (C1P)
DBS Analyst forecast on DE:C1P
Mark Kong CFA
DBS
DBS
€2.9
Buy
70.51%
Upside
Reiterated
03/27/26
Consun Pharmaceutical Group Ltd. (C1P) Receives a Buy from DBS
China Merchants Securities Analyst forecast on DE:C1P
Unknown Analyst
China Merchants Securities
Not Ranked
China Merchants Securities
€1.77
Buy
4.27%
Upside
Reiterated
08/28/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OCGNOcugen
TARAProtara Therapeutics
MIRMMirum Pharmaceuticals
CSTLCastle Biosciences
PCVXVaxcyte
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Consun Pharmaceutical Group Ltd.

3 Months
Mark Kong CFADBS
Success Rate
4/5 ratings generated profit
80%
Average Return
+10.70%
Copying Mark Kong CFA's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +10.70% per trade.
1 Year
Mark Kong CFADBS
Success Rate
4/5 ratings generated profit
80%
Average Return
+63.16%
Copying Mark Kong CFA's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +63.16% per trade.
2 Years
Mark Kong CFADBS
Success Rate
4/5 ratings generated profit
80%
Average Return
+42.60%
Copying Mark Kong CFA's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +42.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

C1P Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
2
2
1
0
Buy
0
1
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
3
3
2
1
In the current month, C1P has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. C1P average Analyst price target in the past 3 months is 2.18.
Each month's total comprises the sum of three months' worth of ratings.

C1P Financial Forecast

C1P Earnings Forecast

The previous quarter’s earnings for C1P were €0.08.
The previous quarter’s earnings for C1P were €0.08.

C1P Sales Forecast

The previous quarter’s earnings for C1P were €225.65M.
The previous quarter’s earnings for C1P were €225.65M.

C1P Stock Forecast FAQ

What is DE:C1P’s average 12-month price target, according to analysts?
Based on analyst ratings, Consun Pharmaceutical Group Ltd.’s 12-month average price target is 2.18.
    What is DE:C1P’s upside potential, based on the analysts’ average price target?
    Consun Pharmaceutical Group Ltd. has 28.31% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Consun Pharmaceutical Group Ltd. a Buy, Sell or Hold?
          Consun Pharmaceutical Group Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Consun Pharmaceutical Group Ltd.’s share price target?
            The average share price target for Consun Pharmaceutical Group Ltd. is 2.18. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €2.39 ,and the lowest forecast is €1.98. The average share price target represents 28.31% Increase from the current price of €1.7.
              What do analysts say about Consun Pharmaceutical Group Ltd.?
              Consun Pharmaceutical Group Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Consun Pharmaceutical Group Ltd.?
                To buy shares of DE:C1P, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.